These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36591660)

  • 21. Diagnostic potential of dentatorubrothalamic tract analysis in progressive supranuclear palsy.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Steiger R; Wildauer M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    Parkinsonism Relat Disord; 2018 Apr; 49():81-87. PubMed ID: 29463454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PSP-Richardson syndrome mimics: An overview and pragmatic approach.
    Necpál J; Borsek M; Jeleňová B
    Rev Neurol (Paris); 2024; 180(1-2):12-23. PubMed ID: 37543508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I; Campbell G; Mangone CA; Verny M; McKee A; Chaudhuri KR; Jellinger K; Pearce RK; D'Olhaberriague L
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.
    Holden SK; Koljack CE; Prizer LP; Sillau SH; Miyasaki JM; Kluger BM
    Parkinsonism Relat Disord; 2019 Aug; 65():172-177. PubMed ID: 31253494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.
    Litvan I; Mangone CA; McKee A; Verny M; Parsa A; Jellinger K; D'Olhaberriague L; Chaudhuri KR; Pearce RK
    J Neurol Neurosurg Psychiatry; 1996 Jun; 60(6):615-20. PubMed ID: 8648326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization and diagnostic potential of R
    Beliveau V; Müller C; Steiger R; Gizewski ER; Poewe W; Seppi K; Scherfler C
    Parkinsonism Relat Disord; 2022 Aug; 101():43-48. PubMed ID: 35792337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Executive dysfunction, behavioral changes and quality of life in Chinese patients with progressive supranuclear palsy.
    Ou R; Liu H; Hou Y; Wei Q; Cao B; Zhao B; Shang H
    J Neurol Sci; 2017 Sep; 380():182-186. PubMed ID: 28870563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Phenotypes of Progressive Supranuclear Palsy-The Differences in Interleukin Patterns.
    Madetko-Alster N; Otto-Ślusarczyk D; Wiercińska-Drapało A; Koziorowski D; Szlufik S; Samborska-Ćwik J; Struga M; Friedman A; Alster P
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stereotypic behaviours in frontotemporal dementia and progressive supranuclear palsy.
    Prioni S; Redaelli V; Soliveri P; Fetoni V; Barocco F; Caffarra P; Scaglioni A; Tramacere I; Girotti F
    Cortex; 2018 Dec; 109():272-278. PubMed ID: 30399478
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy.
    Talai AS; Sedlacik J; Boelmans K; Forkert ND
    Neuroimage Clin; 2018; 20():1037-1043. PubMed ID: 30342392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive and behavioral profile of progressive supranuclear palsy and its phenotypes.
    Horta-Barba A; Pagonabarraga J; Martínez-Horta S; Busteed L; Pascual-Sedano B; Illán-Gala I; Marin-Lahoz J; Aracil-Bolaños I; Pérez-Pérez J; Sampedro F; Bejr-Kasem H; Kulisevsky J
    J Neurol; 2021 Sep; 268(9):3400-3408. PubMed ID: 33704556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acoustical analysis of speech in progressive supranuclear palsy.
    Skodda S; Visser W; Schlegel U
    J Voice; 2011 Nov; 25(6):725-31. PubMed ID: 20457507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine transporter imaging in progressive supranuclear palsy: Severe but nonspecific to subtypes.
    Chen QS; Li XY; Li L; Lu JY; Sun YM; Liu FT; Zuo CT; Wang J
    Acta Neurol Scand; 2022 Sep; 146(3):237-245. PubMed ID: 35611608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
    Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different tau pathology pattern in two clinical phenotypes of progressive supranuclear palsy.
    Jellinger KA
    Neurodegener Dis; 2008; 5(6):339-46. PubMed ID: 18349518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.